Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mercanto HoldingsTGSHF 33 Equity-to-Asset is 0.29 as of Apr. 2026, which is 24% below its 10-year median of 0.38. GuruFocus rates TGSHF with a GF Score™ of 33/100. The stock has 1 warning sign investors should review. Among 1,005 Drug Manufacturers companies, Mercanto Holdings ranks worse than 83.58% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Mercanto Holdings's Total Stockholders Equity for the quarter that ended in Apr. 2026 was $0.36 Mil. Mercanto Holdings's Total Assets for the quarter that ended in Apr. 2026 was $1.23 Mil.
Therefore, Mercanto Holdings's Equity to Asset Ratio for the quarter that ended in Apr. 2026 was 0.29.
The historical rank and industry rank for Mercanto Holdings's Equity-to-Asset or its related term are showing as below:
TGSHF'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.1 Med: 0.38 Max: 0.92
Current: 0.29
During the past 5 years, the highest Equity to Asset Ratio of Mercanto Holdings was 0.92. The lowest was 0.10. And the median was 0.38.
TGSHF's Equity-to-Asset is ranked worse than 83.58% of 1005
companies
in the Drug Manufacturers industry
Industry Median: 0.6
vs TGSHF: 0.29
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Mercanto Holdings Equity-to-Asset Related Terms
Mercanto Holdings Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Mercanto Holdings's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Mercanto Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mercanto Holdings Equity-to-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mercanto Holdings's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Mercanto Holdings's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Mercanto Holdings's Equity to Asset Ratio for the fiscal year that ended in Jul. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mercanto Holdings (TGSHF) has a Equity-to-Asset of 0.29 as of Apr. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Mercanto Holdings and its competitors. This is 24% below median its historical median of 0.38. Over the past decade, Mercanto Holdings' Equity-to-Asset has ranged from 0.10 to 0.92. According to the industry distribution chart, Mercanto Holdings ranks #840 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 83.6%.
Is Mercanto Holdings' Equity-to-Asset too high?
Mercanto Holdings' current Equity-to-Asset of 0.29 is 24% below median its 10-year median of 0.38. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 0.92. The Drug Manufacturers industry median Equity-to-Asset is 0.60. Mercanto Holdings' value of 0.29 is 51.7% below this industry median. Based on the distribution chart, Mercanto Holdings ranks #840 out of 1005 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Mercanto Holdings has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Mercanto Holdings' Equity-to-Asset compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Mercanto Holdings ranks #840 out of 1005 companies for Equity-to-Asset. This places Mercanto Holdings in the lower half of its industry. The industry median Equity-to-Asset is 0.60. Mercanto Holdings' value of 0.29 is 51.7% below this benchmark. Historically, Mercanto Holdings' own Equity-to-Asset has ranged from 0.10 to 0.92 over the past decade. While the company's 10-year median is 0.38 vs. the industry median of 0.60, Mercanto Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.60, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mercanto Holdings's current Equity-to-Asset of 0.29 is 51.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Mercanto Holdings and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mercanto Holdings's current Equity-to-Asset is 0.29, which is 24% below median its own 10-year median of 0.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercanto Holdings stock overvalued right now?
Mercanto Holdings (TGSHF) has a current Equity-to-Asset of 0.29. The current Equity-to-Asset is 0.29, which is 24% below median its 10-year median of 0.38 and 51.7% below the Drug Manufacturers industry median of 0.60. Mercanto Holdings' overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Mercanto Holdings (TGSHF), the current Equity-to-Asset is 0.29 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mercanto Holdings Inc operates a portfolio of brands that include traditional cannabis and beverage products. The company exists to promote the use of mushrooms through its brands; The company offers quality products that promote health, recreation, and well-being. The portfolio of the company includes different cannabis products, probiotic, functional mushroom beverages, and others.
33GF Score
Get the complete analysis for TGSHF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TGSHF has been successfully added to your 
